<?xml version="1.0" encoding="UTF-8"?>
<p>Initial findings of different clinical trials are important first steps to develop efficient treatment against COVID-19.
 <xref rid="cit0041" ref-type="bibr">41</xref> Beigel et al
 <xref rid="cit0032" ref-type="bibr">32</xref> published a randomized, placebo-controlled, multicenter study on remdesivir efficacy against SARS-CoV-2. The report is significant since it is the first report on the efficacy of remdesivir against a novel coronavirus with unknown pathogenesis.
 <xref rid="cit0041" ref-type="bibr">41</xref> Results showed that remdesivir has a moderate clinical efficacy against COVID-19.
 <xref rid="cit0032" ref-type="bibr">32</xref> Findings were preliminary and are followed by more collected data and a full statistical study by all education people.
 <xref rid="cit0041" ref-type="bibr">41</xref>
</p>
